M2-type TAMs are induced by IL-4 and IL-13, leading to the release of immunosuppressive cytokines such as arginase 1, transforming growth factor-β, and IL-10, which promote tumour development while suppressing the immune response (23). The gene discussed is IL10; the disease is neoplasm.